Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Stem Cell Reports ; 17(1): 1-13, 2022 01 11.
Artigo em Inglês | MEDLINE | ID: mdl-34971562

RESUMO

Research in low Earth orbit (LEO) has become more accessible. The 2020 Biomanufacturing in Space Symposium reviewed space-based regenerative medicine research and discussed leveraging LEO to advance biomanufacturing for regenerative medicine applications. The symposium identified areas where financial investments could stimulate advancements overcoming technical barriers. Opportunities in disease modeling, stem-cell-derived products, and biofabrication were highlighted. The symposium will initiate a roadmap to a sustainable market for regenerative medicine biomanufacturing in space. This perspective summarizes the 2020 Biomanufacturing in Space Symposium, highlights key biomanufacturing opportunities in LEO, and lays the framework for a roadmap to regenerative medicine biomanufacturing in space.


Assuntos
Materiais Biocompatíveis , Meio Ambiente Extraterreno , Manufaturas , Medicina Regenerativa , Inteligência Artificial , Automação , Bioengenharia , Humanos , Aprendizado de Máquina , Pesquisa
2.
Tissue Eng Part B Rev ; 18(2): 139-54, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22044424

RESUMO

Regenerative therapies possess high theoretical potential for medical advance yet their success as commercial therapeutics is still open to debate. Appropriate data on target opportunities that provide perspective and enable strategic decision making is necessary for both efficient and effective translation. Up until now, this data have been out of reach to research scientists and many start-up companies-the very groups currently looked to for the critical advance of these therapies. The target-based estimate of opportunity presented in this report demonstrates its importance in evaluating medical need and technology feasibility. In addition, analysis of U.S. research spending, productivity, and innovation reveals that U.S. basic research in this field would benefit from greater interdisciplinarity. Overcoming the barriers that currently prevent translation into high value therapies that are quickly clinically adopted requires simultaneous integration of engineering, science, business, and clinical practice. Achieving this integration is nontrivial.


Assuntos
Eficiência , Medicina Regenerativa/economia , Medicina Regenerativa/organização & administração , Pesquisa Biomédica/economia , Doença , Humanos , Investimentos em Saúde/economia , National Institutes of Health (U.S.) , Inovação Organizacional/economia , Pesquisa com Células-Tronco/economia , Transferência de Tecnologia , Engenharia Tecidual/economia , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...